Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 275.7 M303.53 M290.95 M318.23 M320.57 M 1.23 B Research & development 168.83 M181.74 M176.61 M189.13 M200.41 M 747.88 M Operating income -53.55 M-65.29 M-18.42 M304 K-24.8 M -108.22 M Non-Operating Income, Total 19.05 M24.41 M20.45 M17.81 M50.72 M 113.39 M Interest expense, net of interest capitalized 1.07 M1.47 M801 K-212 K853 K 2.92 M Non-Operating Income, excl. Interest Expenses 20.15 M22.92 M20.24 M19.47 M34.77 M 97.4 M Unusual income/expense -2.16 M10 K-585 K-1.45 M15.1 M 13.07 M Pretax income -33.32 M-43.12 M1.35 M19.4 M8.79 M -13.57 M Equity in earnings ————— — Taxes 4.3 M3.93 M3.36 M3.87 M4.36 M 15.52 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -37.63 M-47.05 M-2.01 M15.53 M4.43 M -29.09 M Discontinued operations ————— — Net income -37.63 M-47.05 M-2.01 M15.53 M4.43 M -29.09 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -37.63 M-47.05 M-2.01 M15.53 M4.43 M -29.09 M Basic earnings per share (Basic EPS) -0.46-0.58-0.020.180.06 -0.36 Diluted earnings per share (Diluted EPS) -0.46-0.58-0.020.190.05 -0.36 Average basic shares outstanding 81.06 M81.08 M81.4 M81.25 M80.36 M — Diluted shares outstanding 81.06 M81.08 M81.4 M81.25 M81.58 M — EBITDA -48.24 M-59.62 M-12.76 M6.04 M-19.25 M -85.58 M EBIT -53.55 M-65.29 M-18.42 M304 K-24.8 M -108.22 M Cost of revenue 158.04 M171.43 M179.18 M187.41 M191.44 M 729.46 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 5.31 M5.68 M5.67 M5.74 M5.55 M 22.64 M